Expressing support for the designation of September 2024 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™House Resolution 1505 from the 118th Congress expresses support for designating September 2024 as "National Polycystic Kidney Disease Awareness Month." The resolution aims to raise public awareness and understanding of polycystic kidney disease (PKD), a genetic disorder characterized by the growth of numerous cysts in the kidneys. The bill was referred to the House Committee on Energy and Commerce but did not advance further and is currently classified as failed or expired. No legislative text or detailed provisions are provided in the available data.
H.Res. 1505 sought to promote awareness of polycystic kidney disease by designating September 2024 as an awareness month but did not progress beyond committee referral and is now expired.
- The bill designates September 2024 as National Polycystic Kidney Disease Awareness Month.
- Its purpose is to raise awareness and understanding of polycystic kidney disease.
- The resolution was referred to the House Committee on Energy and Commerce but did not advance and is classified as failed or expired.
['Individuals affected by polycystic kidney disease and their families', 'Healthcare providers and organizations focused on kidney health', 'Public health awareness campaigns and advocacy groups related to kidney diseases']
['No specific implementation or funding mechanisms are detailed, limiting the scope of impact.', 'As a non-binding resolution, it does not create enforceable obligations or allocate resources.', 'The bill’s failure to advance may limit awareness efforts tied directly to this designation.']
The resolution was introduced in the House of Representatives during the 118th Congress and referred to the House Committee on Energy and Commerce. It is a non-binding measure aimed at raising awareness rather than creating new laws or funding. The bill did not progress beyond committee referral and is now classified as failed or expired, indicating it did not receive a floor vote or enactment.
No hidden impact flags detected
GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public awareness could lead to greater demand for research funding or improved patient support services related to polycystic kidney disease.', 'Healthcare providers and advocacy groups may leverage the awareness month to enhance education and outreach efforts.', 'Potentially increased public knowledge might encourage earlier diagnosis or better disease management among affected individuals.']
The bill is a non-binding resolution without detailed legislative text or funding provisions, limiting transparency into specific implementation plans or oversight mechanisms. Its failure to advance beyond committee referral means no formal congressional debate or amendments were recorded. Monitoring similar future resolutions or related legislative efforts could provide insight into evolving congressional priorities on kidney disease awareness.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.